SCIENCE, PRACTICE AND EDUCATION REFERENCES 1. Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG, Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care. 2020 May; 43(5):964–74. doi:10.2337/dc19-1614. 2. Rastogi A, Goyal G, Kesavan R, Bal A, Kumar H, Mangalanadanam, Kamath P, et al. Long term outcomes after incident diabetic foot ulcer: Multi- center large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complica- tions study: Epidemiology of diabetic foot complica- tions study. Diabetes Res Clin Pract. 2020 Apr; 162:108113. 3. Armstrong DG, Boulton AJM, Bus SA. diabetic foot ulcers and their recurrence. N Engl J Med. 2017 Jun 15; 376(24):2367–75. 4. Toki F, Nanba D, Nishimura EK, Matsuzaki K. Evaluation of the proliferative potential of skin keratinocytes and fibroblasts isolated from critical limb ischemia patients. Regen Ther. 2020 May 15; 14:222–6. 5. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, et al. Prediction of outcome in individuals with diabetic foot ulcers: Focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia. 2008 May; 51(5):747–55. 6. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999 Jan; 22(1):157–62. 7. Hinchliffe RJ, Forsythe RO, Apelqvist J, Boyko EJ, Fitridge R, Hong JP, et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar; 36 Suppl 1:e3276. 8. Lombardo FL, Maggini M, De Bellis A, Seghieri G, Anichini R. Lower extremity amputations in persons with and without diabetes in Italy: 2001–2010. PLoS One. 2014 Jan 28; 9(1):e86405. 9. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med. 2014 Apr 17; 370(16):1514–23. 10. Khan T, Armstrong DG. Ulcer-free, hospital-free and activity-rich days: Three key metrics for the diabetic foot in remission. J Wound Care. 2018 Apr 1; 27(Sup4):S3–4. 11. Jia L, Parker CN, Parker TJ, Kinnear EM, Derhy PH, Alvarado AM, et al. Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers. PLoS One. 2017 May 17; 12(5):e0177916. 12. Ferroni L, Gardin C, De Pieri A, Sambataro M, Seganfreddo E, Goretti C, et al. Treatment of diabetic foot ulcers with Therapeutic Magnetic Resonance (TMR®) improves the quality of granulation tissue. Eur J Histochem. 2017 Aug 7; 61(3):2800. 13. Romanelli M, Piaggesi A, Scapagnini G, Dini V, Janowska A, Iacopi E, et al. EUREKA study - the evaluation of real-life use of a biophotonic system in chronic wound management: an interim analysis. Drug Des Devel Ther. 2017 Dec 11; 11:3551–8. 14. Piaggesi A, Låuchli S, Bassetto F, Biedermann T, Marques A, Najafi B, et al. Advanced therapies in wound management: Cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies. J Wound Care. 2018 Jun 1; 27(Sup6a):S1–137. 15. Zhou Y, Chia HWA, Tang HWK, Lim SYJ, Toh WY, Lim XL, et al. Efficacy of low-level light therapy for improving healing of diabetic foot ulcers: A systematic review and meta-analysis of randomized controlled trials. Wound Repair Regen. 2021 Jan; 29(1):34–44. 16. Santos CMD, Rocha RBD, Hazime FA, Cardoso VS. A systematic review and meta-analysis of the effects of low-level laser therapy in the treatment of diabetic foot ulcers. Int J Low Extrem Wounds. 2020 May 12; doi:10.1177/1534734620914439. 17. Dos Santos Mendes-Costa L, de Lima VG, Barbosa MPR, Dos Santos LE, de Siqueira Rodrigues Fleury Rosa S, Tatmatsu-Rocha JC. Photobiomodulation: Systematic review and meta-analysis of the most used parameters in the resolution diabetic foot ulcers. Lasers Med Sci. 2020 Nov 15; doi:10.1007/ s10103-020-03192-y. Online ahead of print. 18. Hamblin MR, Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochem Photobiol. 2018 Mar; 94(2): 199–212. doi:10.1111/ php.12864. 19. Rossi F, Pini R, De Siena G, Massi D, Pavone FS, Alfieri D, et al. A blue-LED-based device for selective photocoagulation of superficial abrasions: Theoretical modeling and in vivo validation. Photonic Ther Diagnostics. 2010; 7548 (Proceedings of SPIE). 20. Alfieri D, Bacci S, Cicchi R, De Siena G, Lotti V, Pavone F, et al. Blue LED treatment of superficial abrasions. Proceed SPIE. 2013; 8565:85650H- 85650H-6. doi:10.1117/12.2003933. 21. Cicchi R, Rossi F, Alfieri D, Bacci S, Tatini F, De Siena G, et al. Observation of an improved healing process in superficial skin wounds after irradiation with a blue-LED haemostatic device. J Biophotonics. 2016; 9(6):645–55. doi:10.1002/jbio.201500191. 22. Rossi F, Cicchi R, Magni G, Tatini F, Bacci S, Paroli G, et al. In-vivo wound healing modulation after irradiation with a blue LED photocoagulator. Proceed. 2017; 10417, 104:1041706. doi:10.1117/12.2286053. 23. Rossi F, Cicchi R, Magni G, Tatini F, Bacci S, Paroli G, et al. Blue LED induced thermal effects in wound healing: Experimental evidence in an in vivo model of superficial abrasions. Proceed SPIE. 2017; 10066 1006:100660B. doi:10.1117/12.2251947. 24. Magni G, Tatini F, Bacci S, Paroli G, De Siena G, Cicchi R, et al. Blue LED light modulates inflamma- tory infiltrate and improves the healing of superficial wounds. Photodermatol Photoimmunol Photomed. 2019 July 5; 1–3. doi:10.1111/phpp.12527. 25. Magni G, Banchelli M, Cherchi F, Coppi E, Fraccalvieri M, Pugliesi AM, et al. Human keloid cultured fibroblasts irradiated with blue LED light: Evidence from an in vitro study. Proceed SPIE. 2019 July 31; doi:10.1117/12.2527084. 26. Magni G, Cherchi F, Coppi E, Fraccalvieri M, Tatini F, Fusco I, et al. Blue light effects in human keloid fibroblasts. Proceed SPIE. 2019; 1086107(March):6. doi:10.1117/12.2509504. 27. Yang K, Li D, Wang M, Xu Z, Chen X. Exposure to blue light stimulates the proangiogenic capability of exosomes derived from human umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2019 Nov 28; 10(1):358. doi:10.1186/s13287-019-1472-x. 28. Magni G, Tatini F, Bacci S, Paroli G, De Siena G, Cicchi R, et al. Blue LED light modulates inflamma- tory infiltrate and improves the healing of superficial wounds. Photodermatol Photoimmunol Photomed. 2020 Mar; 36(2):166–8. 29. Dini V, Romanelli M, Oranges T, Davini G, Janowska A. Blue light emission in the management of hard to heal wounds: A case series. G Ital Dermatol Venereol. 2020 Jul 28; doi:10.23736/S0392-0488.20.06691-2. Online ahead of print. 30. Mosti G, Gasperini S, Fraccalvieri M, Tripodi C [Internet]. Apporto della luce blu nel processo di guarigione: Casi di studio su lesioni croniche. In: Atti XIV Congresso Nazionale 201, AIUC. Available from: https://bit.ly/2LYi9yw. 31. Mosti G, Gasperini S. Observations made on three patients suffering from ulcers of the lower limbs treated with Blue Light. Chronic Wound Manag Res. 2018: 5: 23–8. 32. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribu- tion of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998 May; 21(5):855–9. 33. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012 Jun; 54(12):e132–73. 34. Piaggesi A, Macchiarini S, Rizzo L, Palumbo F, Tedeschi A, Ambrosini Nobili L, et al. An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: A randomized prospective trial versus traditional fiberglass cast. Diabetes Care 2007 Mar; 30(3):586–90. 35. Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, Martini J, Petit JM, Rayman G, et al. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): An international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018 Mar; 6(3):186–96. 36. Yotsu RR, Pham NM, Oe M, Nagase T, Sanada H, Hara H, et al. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: Neuropathic, ischemic, and neuro- ischemic type. J Diabetes Complications. 2014 Jul-Aug; 28(4):528–35. 37. Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007 Jan; 50(1):18–25. 38. Faglia E, Clerici G, Scatena A, Caminiti M, Curci V, Prisco M, et al. Severity of demographic and clinical characteristics, revascularization feasibility, major amputation, and mortality rate in diabetic patients admitted to a tertiary diabetic foot center for critical limb ischemia: Comparison of 2 cohorts recruited at a 10-year distance. Ann Vasc Surg. 2014 Oct; 28(7):1729–36. 39. European Medicine Agency. Guidance on the management of clinical trials during the Covid- 19(coronavirus) pandemic, version 4. Brussels: European Commission; 2021 April 2. 40. NIH Clinical Center [Internet]. Patient recruitment: Ethics in clinical research. Bethesda, MD: NIH; [2021 March 30; 2021 May 21]. Available at: www. clinicalcenter.nih.gov/recruit/ethics.html, JOURNAL OF WOUND MANAGEMENT 63 OFFICIAL JOURNAL OF THE EUROPEAN WOUND MANAGEMENT ASSOCIATION
Share
Download PDF file
Build your own flipbook